XML 23 R12.htm IDEA: XBRL DOCUMENT v3.22.1
Note 5 - Stockholders' Equity and Dilutive Equity Instruments
 3 Months Ended
Mar. 31, 2022
Notes to Financial Statements  
Stockholders' Equity Note Disclosure [Text Block]

(5)

STOCKHOLDERS' EQUITY AND DILUTIVE EQUITY INSTRUMENTS

 

Accumulated Other Comprehensive Income (Loss)

 

The changes in accumulated other comprehensive income (loss) (OCI) by component, net of tax, for the three months ended March 31, 2022 and 2021 are as follows:

 

(In Thousands)

 

Three Months Ended

 
  March 31, 2022  March 31, 2021 

Balance at December 31, 2021 and 2020

 $2,668  $(804)

Pension benefits recognized in OCI

  (197)  (71)

Balance at March 31, 2022 and 2021

 $2,471  $(875)

 

Dilutive Equity Instruments

 

We had 2,631,247 and 3,171,497 incremental "in-the-money" warrants, restricted stock units and stock options at March 31, 2022 and 2021, respectively, which are as follows:

 

Total shares outstanding including warrants, restricted stock units and stock options

 

March 31, 2022

  

March 31, 2021

 

Common shares outstanding

  41,716,885   40,731,777 

New creditor warrants (strike price $0.001 per common share)

  465,398   657,203 

GulfMark creditor warrants (strike price $0.01 per common share)

  429,812   815,575 

Restricted stock units and stock options

  1,736,037   1,698,719 

Total

  44,348,132   43,903,274 

 

We also had “out-of-the-money” warrants outstanding exercisable for 5,923,399 shares of common stock at both March 31, 2022 and 2021. Included in these “out-of-the-money” warrants are Series A Warrants, Series B Warrants and GLF Equity Warrants which have exercise prices of $57.06, $62.28, and $100.00, respectively, and expire on various dates in 2023 and 2024. No warrants or restricted stock units, whether in the money or out of the money, are included in our loss per share calculations because the effect of such inclusion is antidilutive.